Page last updated: 2024-08-26

paxilline and Cancer of Rectum

paxilline has been researched along with Cancer of Rectum in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abba, MC; Cuartero, V; Ferretti, VA; Garcia-Fabiani, MB; Lacunza, E; Llontop, A; Palma, S; Perez Verdera, PV; Raffa, CI; Rojas Bilbao, E; Zwenger, A1

Other Studies

1 other study(ies) available for paxilline and Cancer of Rectum

ArticleYear
RHBDD2 overexpression promotes a chemoresistant and invasive phenotype to rectal cancer tumors via modulating UPR and focal adhesion genes.
    Biochimica et biophysica acta. Molecular basis of disease, 2020, 08-01, Volume: 1866, Issue:8

    Topics: Antimetabolites, Antineoplastic; Caco-2 Cells; Cell Adhesion; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Fluorouracil; Focal Adhesion Kinase 1; Focal Adhesions; Gene Expression Regulation, Neoplastic; HCT116 Cells; Heat-Shock Proteins; Humans; Lymphatic Metastasis; Membrane Proteins; Neoadjuvant Therapy; Paxillin; Protein Binding; Rectal Neoplasms; Signal Transduction; Transcription Factor CHOP; Unfolded Protein Response

2020